GEDALY, R., ANGULO, P., HUNDLEY, J., DAILY, M. F., CHEN, C., KOCH, A., & EVERS, B. M. (2010). PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways.

GEDALY, ROBERTO, PAUL ANGULO, JONATHAN HUNDLEY, MICHAEL F. DAILY, CHANGGUO CHEN, ALVARO KOCH, e B. MARK EVERS. PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation By Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways. 2010.

GEDALY, ROBERTO, et al. PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation By Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways. 2010.